Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system (CNS) active compounds. Its structure supports the creation of bioactive molecules with potential applications in treating neurological disorders such as depression, anxiety, and Parkinson’s disease. The fluorinated tetrahydroisoquinoline core enhances metabolic stability and blood-brain barrier penetration, making it valuable in medicinal chemistry for designing potent and selective drug candidates.